Biological evaluation of porous nanocomposite scaffolds based on strontium substituted β-TCP and bioactive glass: An in vitro and in vivo study.

Author(s) Kazemi, M.; Dehghan, M.Mehdi; Azami, M.
Journal Mater Sci Eng C Mater Biol Appl
Date Published 2019 Dec
Abstract

In the current study, in vitro analysis of the osteogenic potential of different scaffolds based on strontium-substituted β-TCP (Sr-TCP) and bioactive glass (BG) ceramics was conducted using rabbit bone marrow-derived mesenchymal stem cells (rBMSCs) and the osteogenic ability of the prepared Sr-TCP and BG scaffold was evaluated through alkaline phosphatase activity, mineral deposition by Alizarin red staining, and osteoblastic gene expression experiments. The obtained in vitro results revealed that among experimental Sr-TCP/BG nanocomposite scaffold samples with the composition of Sr-TCP/BG: 100/0, 50/50, 75/25, and 25/75, the 50Sr-TCP/50BG sample presented better osteoinductive properties. Therefore, the optimized 50Sr-TCP/50BG nanocomposite scaffold was chosen for further in vivo experiments. In vivo implantation of 50Sr-TCP/50BG scaffold and hydroxyapatite (HA)/TCP granules in a rabbit calvarial defect model showed slow degradation of 50Sr-TCP/50BG scaffold and high resorption rate of HA/TCP granules at 5 months' post-surgery. However, the 50Sr-TCP/50BG scaffolds loaded by mesenchymal stem cells (MSCs) were mainly replaced with new bone even at 2 months post-implantation. Based on the obtained engineering and biological results, 50Sr-TCP/50BG nanocomposite scaffold containing MSCs could be considered as a promising alternative substitute even for load-bearing bone tissue engineering applications.

DOI 10.1016/j.msec.2019.110071
ISSN 1873-0191
Citation Kazemi M, Dehghan MM, Azami M. Biological evaluation of porous nanocomposite scaffolds based on strontium substituted β-TCP and bioactive glass: An in vitro and in vivo study. Mater Sci Eng C Mater Biol Appl. 2019;105:110071.